title: Response to article by Forné et al.
authors.forename: J P
authors.initials: JP
authors.lastname: Gisbert
authors.forename: D
authors.initials: D
authors.lastname: Boixeda
authors.forename: C
authors.initials: C
authors.lastname: Martín de Argila
authors.forename: M
authors.initials: M
authors.lastname: Mur Villacampa
authors.forename: J
authors.initials: J
authors.lastname: Monés
authors.forename: R
authors.initials: R
authors.lastname: Sáinz Samitier
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003102:Colloids; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D000900:Anti-Bacterial Agents; D003102:Colloids; D017291:Clarithromycin; C010804:bismuth subnitrate; D009853:Omeprazole; D001729:Bismuth